Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis.

Ouyang, Boshu; Deng, Lingling; Yang, Fangyong; Shi, Hanlin; Wang, Na; Tang, Weifeng; Huang, Xi; Zhou, Yaolong; Yu, Hang; Wei, Ying; Dong, Jingcheng

Ouyang, Boshu; Deng, Lingling; Yang, Fangyong; Shi, Hanlin; Wang, Na; Tang, Weifeng; Huang, Xi; Zhou, Yaolong; Yu, Hang; Wei, Ying; Dong, Jingcheng.

Afiliación

Ouyang B; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.
Deng L; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, PR China.
Yang F; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.
Shi H; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, PR China.
Wang N; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.
Tang W; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, PR China.
Huang X; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.
Zhou Y; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, PR China.
Yu H; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.
Wei Y; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, PR China.
Dong J; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, PR China.

Mater Today Bio ; 20: 100643, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37214555

Palabras clave

Fibrosis; Formononetin; Lung injury; Macrophage pyroptosis; NLRP3; SPARC

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mater Today Bio Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google